Monday March 23, 2026
A clear pattern is emerging this week: scale is being engineered, not just acquired — from billion-dollar bets in diagnostics to targeted capability add-ons across manufacturing, delivery, and sensing.
8 things to watch this week:
1. 🧬 Abbott completes Exact Sciences acquisition
Abbott is doubling down on diagnostics as a growth engine, signaling continued convergence between testing, monitoring, and intervention. This move strengthens its position across the full care pathway.
MassDevice
2. 🩻 GE HealthCare’s Photonova Spectra photon-counting CT receives FDA clearance
Photon-counting CT has long been viewed as the next frontier in imaging, and this clearance pushes it into real-world deployment. Expect competitive acceleration in advanced imaging platforms.
BusinessWire
3. 🔎 Before You Raise, Launch, or Scale — Know If You’re Actually Ready
Medical device companies rarely fail because the technology doesn’t work.
They fail because commercialization, reimbursement, and adoption strategy weren’t aligned early enough. RŌG Health helps medtech leaders assess whether their company is truly ready for key milestones such as FDA clearance, fundraising, and market launch.
Take our 1-minute readiness check to see where your strategy stands — and discover the engagement path designed for your stage. →
Sponsored
4. ⌚ FDA clears Mode Sensors fluid monitoring wearable
Continuous fluid monitoring via wearable sensors opens new pathways for managing chronic conditions outside the hospital. This is another step toward clinically relevant, always-on patient monitoring.
MSN
5. 💉 Embecta: $150 Million Acquisition Of Owen Mumford To Expand Drug Delivery Platform Capabilities
Embecta is expanding beyond insulin delivery into a broader drug delivery platform, signaling a push toward owning more of the therapeutic delivery stack.
Pulse2
6. 🏭 Resonetics completes the acquisition of Resolution Medical
This acquisition strengthens Resonetics’ position as an end-to-end manufacturing partner, reflecting growing demand for vertically integrated medtech development and production.
PR Newswire
7. 📊 Report says US cardiovascular devices market to reach $41.29 billion by 2032
The projected growth underscores sustained demand in cardiovascular care, reinforcing why strategics continue to prioritize investment and acquisition in this category.
DAIC
8. 🤝 Ibex and HNL Lab partner on prostate cancer diagnostics
AI-driven diagnostics continue to expand into clinical workflows, with partnerships like this accelerating adoption in pathology and cancer detection.
Medical Device Network
Want to put your brand in front of 35,000+ medical device and med tech leaders each week? Contact us to learn more about sponsorship opportunities.
🧭 About The Pathway
The Pathway is a curated briefing for medical device leaders, focused on regulatory moves, product launches, partnerships, and market signals shaping the industry.
If this was useful, consider subscribing or sharing with a colleague who should be tracking these developments.
Some issues may include sponsored or partner content. Sponsorship does not influence editorial selection of third-party news items.